To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Efficacy Of Low-Dose Esketamine Weakly Opioidized Anesthesia In Elderly Patients Undergoing Surgery

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2025

Efficacy Of Low-Dose Esketamine Weakly Opioidized Anesthesia In Elderly Patients Undergoing Surgery

Vol: 307| Issue: 5| Number:4| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial.

BMC Anesthesiol. 2025 Feb 5;25(1):57.

Contributing Authors:
NN Hou MY Zhang YW Zhang HJ Wu H Luo H Yang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety elderly patients with lumbar spinal stenosis were randomized to receive high-dose esketamine (HS) (n=30), low-dose esketamine (LS) (n=30), or saline (control, C) (n=30) during total laminectomy and interbody fusion surgery. The primary outcome was the cumulative perioperative dose of sufentanil. Secondary outcomes included pain scores (VAS) at rest and during movement, serum inflammatory bi...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue